| Year |
Citation |
Score |
| 2023 |
Khan DMIO, Karmaus PWF, Bach A, Crawford RB, Kaminski NE. An in vitro model of human hematopoiesis identifies a regulatory role for the aryl hydrocarbon receptor. Blood Advances. PMID 37477592 DOI: 10.1182/bloodadvances.2023010169 |
0.336 |
|
| 2022 |
Blevins LK, Bach AP, Crawford RB, Zhou J, Henriquez JE, Rizzo MD, Sermet S, Khan DMIO, Turner H, Small-Howard AL, Kaminski NE. Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa L employing human primary leukocytes. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 113458. PMID 36228902 DOI: 10.1016/j.fct.2022.113458 |
0.312 |
|
| 2022 |
Zhou J, Blevins LK, Crawford RB, Kaminski NE. Role of Programmed Cell Death Protein-1 and Lymphocyte Specific Protein Tyrosine Kinase in the Aryl Hydrocarbon Receptor- Mediated Impairment of the IgM Response in Human CD5 Innate-Like B Cells. Frontiers in Immunology. 13: 884203. PMID 35558082 DOI: 10.3389/fimmu.2022.884203 |
0.365 |
|
| 2021 |
Blevins LK, Zhou J, Crawford RB, Kaminski NE. Identification of a Sensitive Human Immunological Target of Aryl Hydrocarbon Receptor Activation: CD5 Innate-Like B Cells. Frontiers in Immunology. 12: 635748. PMID 33936048 DOI: 10.3389/fimmu.2021.635748 |
0.403 |
|
| 2020 |
Henriquez JE, Bach AP, Matos-Fernandez KM, Crawford RB, Kaminski NE. Δ-Tetrahydrocannabinol (THC) Impairs CD8 T Cell-Mediated Activation of Astrocytes. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 32215844 DOI: 10.1007/s11481-020-09912-z |
0.414 |
|
| 2019 |
Blevins LK, Zhou J, Crawford R, Kaminski NE. TCDD-mediated suppression of naïve human B cell IgM secretion involves aryl hydrocarbon receptor-mediated reduction in STAT3 serine 727 phosphorylation and is restored by Interferon-γ. Cellular Signalling. 109447. PMID 31678681 DOI: 10.1016/j.cellsig.2019.109447 |
0.347 |
|
| 2019 |
Henriquez JE, Crawford RB, Kaminski NE. Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists. Toxicology and Applied Pharmacology. PMID 30807757 DOI: 10.1016/j.taap.2019.02.013 |
0.371 |
|
| 2018 |
Dornbos P, Warren M, Crawford RB, Kaminski N, Threadgill DW, LaPres JJ. Characterizing Serpinb2 as a modulator of TCDD-induced suppression of the B cell. Chemical Research in Toxicology. PMID 30339366 DOI: 10.1021/Acs.Chemrestox.8B00225 |
0.367 |
|
| 2018 |
Henriquez JE, Rizzo MD, Crawford RB, Gulick P, Kaminski NE. Interferon- α-mediated Activation of T Cells from Healthy and HIV-infected Individuals is Suppressed by Δ -Tetrahydrocannabinol . The Journal of Pharmacology and Experimental Therapeutics. PMID 30026298 DOI: 10.1124/jpet.118.250308 |
0.313 |
|
| 2018 |
Zhou J, Zhang Q, Henriquez JE, Crawford RB, Kaminski NE. Lymphocyte-specific protein tyrosine kinase (LCK) is involved in the aryl hydrocarbon receptor (AHR)-mediated impairment of immunoglobulin secretion in human primary B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 29860352 DOI: 10.1093/toxsci/kfy133 |
0.361 |
|
| 2018 |
Zhou J, Henriquez J, Crawford R, Kaminski N. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B cells involves Impairment of Immunoglobulin Secretory Processes. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 29462421 DOI: 10.1093/Toxsci/Kfy036 |
0.492 |
|
| 2018 |
Li J, Bach A, Crawford RB, Phadnis-Moghe AS, Chen W, D'Ingillo S, Kovalova N, Suarez-Martinez JE, Zhou J, Kaplan BLF, Kaminski NE. CLARITY-BPA: Effects of Chronic Bisphenol A Exposure on the Immune System: Part 1 - Quantification of the relative number and proportion of leukocyte populations in the spleen and thymus. Toxicology. PMID 29428349 DOI: 10.1016/J.Tox.2018.01.004 |
0.426 |
|
| 2018 |
Li J, Bach A, Crawford RB, Phadnis-Moghe AS, Chen W, D'Ingillo S, Kovalova N, Suarez-Martinez JE, Zhou J, Kaplan BLF, Kaminski NE. CLARITY-BPA: Effects of Chronic Bisphenol A Exposure on the Immune System: Part 2 - Characterization of Lymphoproliferative and Immune Effector Responses by Splenic Leukocytes. Toxicology. PMID 29427786 DOI: 10.1016/J.Tox.2018.02.004 |
0.468 |
|
| 2017 |
Henriquez J, Zhou J, Li J, Crawford R, Kaminski N. Application of gene specific mRNA level determinations in individual cells using flow cytometry-based PrimeFlow™ in immunotoxicology. Toxicology and Applied Pharmacology. 337: 39-44. PMID 29107001 DOI: 10.1016/J.Taap.2017.10.021 |
0.347 |
|
| 2017 |
Li J, Bhattacharya S, Zhou J, Phadnis-Moghe AS, Crawford RB, Kaminski NE. Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis. Journal of Immunology (Baltimore, Md. : 1950). PMID 28978690 DOI: 10.4049/Jimmunol.1700289 |
0.347 |
|
| 2017 |
Stedtfeld RD, Chai B, Crawford RB, Stedtfeld TM, Williams MR, Xiangwen S, Kuwahara T, Cole JR, Kaminski NE, Tiedje JM, Hashsham SA. Modulatory Influence of Segmented Filamentous Bacteria on Transcriptomic Response of Gnotobiotic Mice Exposed to TCDD. Frontiers in Microbiology. 8: 1708. PMID 28936204 DOI: 10.3389/Fmicb.2017.01708 |
0.339 |
|
| 2016 |
Li J, Phadnis-Moghe AS, Crawford RB, Kaminski NE. Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis. Toxicology. PMID 28049042 DOI: 10.1016/j.tox.2016.12.010 |
0.348 |
|
| 2016 |
Kovalova N, Nault R, Crawford R, Zacharewski TR, Kaminski NE. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells. Toxicology and Applied Pharmacology. PMID 27913140 DOI: 10.1016/J.Taap.2016.11.009 |
0.348 |
|
| 2016 |
Phadnis-Moghe A, Chen W, Li J, Crawford RB, Bach T, D'Ingillo S, Kovalova N, Suarez-Martinez JE, Kaplan BL, Harrill JA, Budinsky R, Rowlands JC, Thomas RS, Kaminski NE. Immunological Characterization of the Aryl Hydrocarbon Receptor (AHR) Knockout Rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology. PMID 27590929 DOI: 10.1016/J.Tox.2016.08.019 |
0.741 |
|
| 2016 |
Phadnis-Moghe AS, Li J, Crawford RB, Kaminski NE. SHP-1 is Directly Activated by the Aryl Hydrocarbon Receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology and Applied Pharmacology. PMID 27546522 DOI: 10.1016/j.taap.2016.08.014 |
0.341 |
|
| 2016 |
Kovalova N, Manzan M, Crawford R, Kaminski N. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells. Toxicology and Applied Pharmacology. PMID 27535091 DOI: 10.1016/J.Taap.2016.08.011 |
0.417 |
|
| 2016 |
Aldhamen YA, Rastall DP, Chen W, Seregin SS, Pereira-Hicks C, Godbehere S, Kaminski NE, Amalfitano A. CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T cell immune responses to antigenic targets. Vaccine. PMID 27151882 DOI: 10.1016/J.Vaccine.2016.04.068 |
0.51 |
|
| 2015 |
Chen W, Crawford RB, Kaplan BL, Kaminski NE. Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ(9)-Tetrahydrocannabinol. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 344-55. PMID 25900076 DOI: 10.1007/S11481-015-9597-X |
0.75 |
|
| 2015 |
Phadnis-Moghe AS, Crawford RB, Kaminski NE. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Toxicological Sciences : An Official Journal of the Society of Toxicology. 144: 39-50. PMID 25543051 DOI: 10.1093/toxsci/kfu257 |
0.389 |
|
| 2014 |
Chen W, Zhang Q, Kaplan BL, Baker GL, Kaminski NE. Induced T cell cytokine production is enhanced by engineered nanoparticles. Nanotoxicology. 8: 11-23. PMID 24256152 DOI: 10.3109/17435390.2013.848302 |
0.734 |
|
| 2014 |
Budinsky RA, Schrenk D, Simon T, Van den Berg M, Reichard JF, Silkworth JB, Aylward LL, Brix A, Gasiewicz T, Kaminski N, Perdew G, Starr TB, Walker NJ, Rowlands JC. Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study. Critical Reviews in Toxicology. 44: 83-119. PMID 24245878 DOI: 10.3109/10408444.2013.835787 |
0.34 |
|
| 2013 |
Ngaotepprutaram T, Kaplan BL, Kaminski NE. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells. Toxicology and Applied Pharmacology. 273: 209-18. PMID 23999542 DOI: 10.1016/J.Taap.2013.08.023 |
0.812 |
|
| 2013 |
Brandenberger C, Rowley NL, Jackson-Humbles DN, Zhang Q, Bramble LA, Lewandowski RP, Wagner JG, Chen W, Kaplan BL, Kaminski NE, Baker GL, Worden RM, Harkema JR. Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice. Particle and Fibre Toxicology. 10: 26. PMID 23815813 DOI: 10.1186/1743-8977-10-26 |
0.671 |
|
| 2013 |
Ngaotepprutaram T, Kaplan BL, Carney S, Crawford R, Kaminski NE. Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation. Toxicology. 310: 84-91. PMID 23727458 DOI: 10.1016/J.Tox.2013.05.009 |
0.815 |
|
| 2013 |
Zhang Q, Kline DE, Bhattacharya S, Crawford RB, Conolly RB, Thomas RS, Andersen ME, Kaminski NE. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 268: 17-26. PMID 23357550 DOI: 10.1016/J.Taap.2013.01.015 |
0.329 |
|
| 2013 |
Karmaus PW, Wagner JG, Harkema JR, Kaminski NE, Kaplan BL. Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice. Journal of Immunotoxicology. 10: 321-8. PMID 23173851 DOI: 10.3109/1547691X.2012.741628 |
0.803 |
|
| 2013 |
Karmaus PW, Chen W, Crawford R, Kaplan BL, Kaminski NE. Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. Toxicological Sciences : An Official Journal of the Society of Toxicology. 131: 419-33. PMID 23152191 DOI: 10.1093/Toxsci/Kfs315 |
0.83 |
|
| 2012 |
Chen W, Kaplan BL, Pike ST, Topper LA, Lichorobiec NR, Simmons SO, Ramabhadran R, Kaminski NE. Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120. Journal of Leukocyte Biology. 92: 1093-102. PMID 22899554 DOI: 10.1189/Jlb.0212082 |
0.74 |
|
| 2012 |
Ngaotepprutaram T, Kaplan BL, Crawford RB, Kaminski NE. Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 969-80. PMID 22851303 DOI: 10.1007/S11481-012-9390-Z |
0.804 |
|
| 2012 |
Raman P, Kaplan BL, Kaminski NE. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells. The Journal of Pharmacology and Experimental Therapeutics. 342: 816-26. PMID 22700433 DOI: 10.1124/Jpet.112.193003 |
0.749 |
|
| 2012 |
Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SS, Lehner A, Kaminski NE, Goudreau JL, Lookingland KJ, Kaplan BL. Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 533-8. PMID 22639229 DOI: 10.1007/S11481-012-9375-Y |
0.614 |
|
| 2012 |
Karmaus PW, Chen W, Kaplan BL, Kaminski NE. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 843-55. PMID 21789506 DOI: 10.1007/S11481-011-9293-4 |
0.821 |
|
| 2011 |
Boyd SA, Johnston CT, Pinnavaia TJ, Kaminski NE, Teppen BJ, Li H, Khan B, Crawford RB, Kovalova N, Kim SS, Shao H, Gu C, Kaplan BL. Suppression of humoral immune responses by 2,3,7,8-tetrachlorodibenzo-p-dioxin intercalated in smectite clay. Environmental Toxicology and Chemistry / Setac. 30: 2748-55. PMID 21994089 DOI: 10.1002/Etc.701 |
0.593 |
|
| 2011 |
Karmaus PW, Chen W, Crawford RB, Harkema JR, Kaplan BL, Kaminski NE. Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection. Journal of Leukocyte Biology. 90: 983-95. PMID 21873455 DOI: 10.1189/Jlb.0511219 |
0.831 |
|
| 2011 |
Lu H, Crawford RB, Kaplan BL, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells. Toxicology and Applied Pharmacology. 255: 251-60. PMID 21807014 DOI: 10.1016/J.Taap.2011.06.026 |
0.77 |
|
| 2011 |
Raman P, Kaplan BL, Thompson JT, Vanden Heuvel JP, Kaminski NE. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. Molecular Pharmacology. 80: 201-9. PMID 21511917 DOI: 10.1124/Mol.110.070441 |
0.752 |
|
| 2011 |
De Abrew KN, Phadnis AS, Crawford RB, Kaminski NE, Thomas RS. Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 252: 150-8. PMID 21296099 DOI: 10.1016/J.Taap.2011.01.020 |
0.787 |
|
| 2011 |
Kaplan BL, Crawford RB, Kovalova N, Arencibia A, Kim SS, Pinnavaia TJ, Boyd SA, Teppen BJ, Kaminski NE. TCDD adsorbed on silica as a model for TCDD contaminated soils: Evidence for suppression of humoral immunity in mice. Toxicology. 282: 82-7. PMID 21272611 DOI: 10.1016/J.Tox.2011.01.013 |
0.676 |
|
| 2011 |
McClure EA, North CM, Kaminski NE, Goodman JI. Changes in DNA methylation and gene expression during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced suppression of the lipopolysaccharide-stimulated IgM response in splenocytes Toxicological Sciences. 120: 339-348. PMID 21212295 DOI: 10.1093/Toxsci/Kfq396 |
0.706 |
|
| 2011 |
Sulentic CE, Kaminski NE. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicological Sciences : An Official Journal of the Society of Toxicology. 120: S171-91. PMID 20952503 DOI: 10.1093/toxsci/kfq324 |
0.331 |
|
| 2010 |
Lu H, Crawford RB, Suarez-Martinez JE, Kaplan BL, Kaminski NE. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 118: 86-97. PMID 20702590 DOI: 10.1093/Toxsci/Kfq234 |
0.761 |
|
| 2010 |
Zhang Q, Bhattacharya S, Kline DE, Crawford RB, Conolly RB, Thomas RS, Kaminski NE, Andersen ME. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin. Bmc Systems Biology. 4: 40. PMID 20359356 DOI: 10.1186/1752-0509-4-40 |
0.339 |
|
| 2010 |
North CM, Crawford RB, Lu H, Kaminski NE. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 116: 99-112. PMID 20348231 DOI: 10.1093/Toxsci/Kfq095 |
0.794 |
|
| 2010 |
Kaplan BL, Lawver JE, Karmaus PW, Ngaotepprutaram T, Birmingham NP, Harkema JR, Kaminski NE. The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicologic Pathology. 38: 382-92. PMID 20190202 DOI: 10.1177/0192623310362706 |
0.783 |
|
| 2010 |
Bhattacharya S, Conolly RB, Kaminski NE, Thomas RS, Andersen ME, Zhang Q. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicological Sciences : An Official Journal of the Society of Toxicology. 115: 51-65. PMID 20123757 DOI: 10.1093/Toxsci/Kfq035 |
0.312 |
|
| 2009 |
Lu H, Crawford RB, North CM, Kaplan BL, Kaminski NE. Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 112: 363-73. PMID 19767444 DOI: 10.1093/Toxsci/Kfp224 |
0.812 |
|
| 2009 |
North CM, Crawford RB, Lu H, Kaminski NE. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response. Toxicological Sciences : An Official Journal of the Society of Toxicology. 112: 123-32. PMID 19675145 DOI: 10.1093/Toxsci/Kfp187 |
0.802 |
|
| 2009 |
Schneider D, Manzan MA, Yoo BS, Crawford RB, Kaminski N. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 108: 377-88. PMID 19237549 DOI: 10.1093/Toxsci/Kfp028 |
0.645 |
|
| 2009 |
Lu H, Kaplan BL, Ngaotepprutaram T, Kaminski NE. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 85: 322-9. PMID 18988696 DOI: 10.1189/Jlb.0608390 |
0.816 |
|
| 2009 |
North CM, Kim BS, Snyder N, Crawford RB, Holsapple MP, Kaminski NE. TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma. Toxicological Sciences : An Official Journal of the Society of Toxicology. 107: 85-92. PMID 18948302 DOI: 10.1093/Toxsci/Kfn223 |
0.726 |
|
| 2008 |
Buchweitz JP, Karmaus PWF, Williams KJ, Harkema JR, Kaminski NE. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Δ9 -tetrahydrocannabinol. Journal of Leukocyte Biology. 83: 785-796. PMID 29350853 DOI: 10.1189/jlb.0907618 |
0.711 |
|
| 2008 |
Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 84: 1574-84. PMID 18791168 DOI: 10.1189/jlb.0508282 |
0.838 |
|
| 2008 |
Kaplan BL, Springs AE, Kaminski NE. The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Biochemical Pharmacology. 76: 726-37. PMID 18656454 DOI: 10.1016/j.bcp.2008.06.022 |
0.738 |
|
| 2008 |
Rockwell CE, Raman P, Kaplan BL, Kaminski NE. A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells. Biochemical Pharmacology. 76: 353-61. PMID 18571623 DOI: 10.1016/J.Bcp.2008.05.005 |
0.808 |
|
| 2008 |
Schneider D, Manzan MA, Crawford RB, Chen W, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. The Journal of Pharmacology and Experimental Therapeutics. 326: 463-74. PMID 18483191 DOI: 10.1124/Jpet.108.139857 |
0.662 |
|
| 2008 |
Buchweitz JP, Karmaus PW, Williams KJ, Harkema JR, Kaminski NE. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 83: 785-96. PMID 18073275 DOI: 10.1189/Jlb.0907618 |
0.818 |
|
| 2007 |
Buchweitz JP, Karmaus PW, Harkema JR, Williams KJ, Kaminski NE. Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice. The Journal of Pharmacology and Experimental Therapeutics. 323: 675-83. PMID 17726158 DOI: 10.1124/Jpet.107.124719 |
0.823 |
|
| 2007 |
Buchweitz JP, Harkema JR, Kaminski NE. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicologic Pathology. 35: 424-35. PMID 17487773 DOI: 10.1080/01926230701302558 |
0.687 |
|
| 2006 |
Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, Kaminski NE. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. Molecular Pharmacology. 70: 101-11. PMID 16611855 DOI: 10.1124/Mol.105.019117 |
0.696 |
|
| 2006 |
Farraj AK, Harkema JR, Kaminski NE. Topical application versus intranasal instillation: a qualitative comparison of the effect of the route of sensitization on trimellitic anhydride-induced allergic rhinitis in A/J mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 92: 321-8. PMID 16611626 DOI: 10.1093/Toxsci/Kfj191 |
0.643 |
|
| 2005 |
Kaplan BL, Ouyang Y, Herring A, Yea SS, Razdan R, Kaminski NE. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. Toxicology and Applied Pharmacology. 205: 107-15. PMID 15893538 DOI: 10.1016/j.taap.2004.09.013 |
0.66 |
|
| 2005 |
Kaplan BL, Ouyang Y, Rockwell CE, Rao GK, Kaminski NE. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. Journal of Leukocyte Biology. 77: 966-74. PMID 15774549 DOI: 10.1189/Jlb.1104652 |
0.782 |
|
| 2004 |
Boverhof DR, Tam E, Harney AS, Crawford RB, Kaminski NE, Zacharewski TR. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells. Molecular Pharmacology. 66: 1662-70. PMID 15371557 DOI: 10.1124/Mol.104.002915 |
0.387 |
|
| 2004 |
Rockwell CE, Kaminski NE. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. The Journal of Pharmacology and Experimental Therapeutics. 311: 683-90. PMID 15284281 DOI: 10.1124/Jpet.104.065524 |
0.664 |
|
| 2004 |
Farraj AK, Harkema JR, Kaminski NE. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 79: 315-25. PMID 15056815 DOI: 10.1093/Toxsci/Kfh112 |
0.641 |
|
| 2004 |
McKarns SC, Schwartz RH, Kaminski NE. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. Journal of Immunology (Baltimore, Md. : 1950). 172: 4275-84. PMID 15034041 DOI: 10.4049/Jimmunol.172.7.4275 |
0.751 |
|
| 2004 |
Rao GK, Zhang W, Kaminski NE. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells. Journal of Leukocyte Biology. 75: 884-92. PMID 14966196 DOI: 10.1189/jlb.1203638 |
0.332 |
|
| 2004 |
Yoo BS, Boverhof DR, Shnaider D, Crawford RB, Zacharewski TR, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 77: 272-9. PMID 14600275 DOI: 10.1093/Toxsci/Kfh013 |
0.351 |
|
| 2003 |
McKarns SC, Letterio JJ, Kaminski NE. Concentration-dependent bifunctional effect of TGF-beta 1 on immunoglobulin production: a role for Smad3 in IgA production in vitro. International Immunopharmacology. 3: 1761-74. PMID 14636827 DOI: 10.1016/J.Intimp.2003.08.001 |
0.707 |
|
| 2003 |
Crawford RB, Sulentic CE, Yoo BS, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 75: 333-42. PMID 12883080 DOI: 10.1093/toxsci/kfg199 |
0.31 |
|
| 2003 |
Farraj AK, Harkema JR, Jan TR, Kaminski NE. Immune responses in the lung and local lymph node of A/J mice to intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicologic Pathology. 31: 432-47. PMID 12851108 DOI: 10.1080/01926230390213766 |
0.747 |
|
| 2003 |
Kaplan BL, Rockwell CE, Kaminski NE. Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. The Journal of Pharmacology and Experimental Therapeutics. 306: 1077-85. PMID 12805480 DOI: 10.1124/Jpet.103.051961 |
0.777 |
|
| 2003 |
Jan TR, Farraj AK, Harkema JR, Kaminski NE. Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. Toxicology and Applied Pharmacology. 188: 24-35. PMID 12668119 DOI: 10.1016/S0041-008X(03)00010-3 |
0.748 |
|
| 2003 |
Suh J, Kang JS, Yang KH, Kaminski NE. Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls. Toxicology and Applied Pharmacology. 187: 11-21. PMID 12628580 DOI: 10.1016/S0041-008X(02)00040-6 |
0.344 |
|
| 2002 |
Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE, Yang KH. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicology and Applied Pharmacology. 181: 116-23. PMID 12051995 DOI: 10.1006/taap.2002.9403 |
0.336 |
|
| 2002 |
Jan TR, Rao GK, Kaminski NE. Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity. Molecular Pharmacology. 61: 446-54. PMID 11809870 DOI: 10.1124/mol.61.2.446 |
0.601 |
|
| 2001 |
Jan TR, Kaminski NE. Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol. Journal of Leukocyte Biology. 69: 841-9. PMID 11358994 |
0.585 |
|
| 2001 |
Li X, Kaminski NE, Fischer LJ. Examination of the immunosuppressive effect of Δ9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes International Immunopharmacology. 1: 699-712. PMID 11357882 DOI: 10.1016/S1567-5769(01)00003-0 |
0.306 |
|
| 2000 |
Sulentic CEW, Holsapple MP, Kaminski NE. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway Journal of Pharmacology and Experimental Therapeutics. 295: 705-716. PMID 11046109 |
0.318 |
|
| 2000 |
McKarns SC, Kaminski NE. TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes. Immunopharmacology. 48: 101-15. PMID 10936508 DOI: 10.1016/S0162-3109(00)00183-1 |
0.727 |
|
| 2000 |
Yea SS, Yang KH, Kaminski NE. Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T- cells Journal of Pharmacology and Experimental Therapeutics. 292: 597-605. PMID 10640296 |
0.325 |
|
| 1998 |
Marcus RS, Holsapple MP, Kaminski NE. Lipopolysaccharide activation of murine splenocytes and splenic B cells increased the expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator Journal of Pharmacology and Experimental Therapeutics. 287: 1113-1118. PMID 9864300 |
0.313 |
|
| 1998 |
Kaminski NE. Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors Journal of Neuroimmunology. 83: 124-132. PMID 9610680 DOI: 10.1016/S0165-5728(97)00228-2 |
0.352 |
|
| 1998 |
Herring AC, Koh WS, Kaminski NE. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and κB elements by cannabinol, a minimally CNS-active cannabinoid Biochemical Pharmacology. 55: 1013-1023. PMID 9605425 DOI: 10.1016/S0006-2952(97)00630-8 |
0.365 |
|
| 1998 |
Ouyang Y, Hwang SG, Han SH, Kaminski NE. Suppression of interleukin-2 by the putative endogenous cannabinoid 2- arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells Molecular Pharmacology. 53: 676-683. PMID 9547358 |
0.332 |
|
| 1998 |
Sulentic CEW, Holsapple MP, Kaminski NE. Aryl hydrocarbon receptor-dependent suppression by 2,3,7,8- tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells Molecular Pharmacology. 53: 623-629. PMID 9547351 |
0.358 |
|
| 1997 |
Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicology and Applied Pharmacology. 142: 278-87. PMID 9070350 DOI: 10.1006/taap.1996.8034 |
0.344 |
|
| 1996 |
Condie R, Herring A, Koh WS, Lee M, Kaminski NE. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2. The Journal of Biological Chemistry. 271: 13175-83. PMID 8662742 DOI: 10.1074/jbc.271.22.13175 |
0.301 |
|
| 1996 |
Koh WS, Lee M, Yang KH, Kaminski NE. Expression of functional glucagon receptors on lymphoid cells Life Sciences. 58: 741-751. PMID 8632721 DOI: 10.1016/0024-3205(95)02352-6 |
0.398 |
|
| 1995 |
Koh WS, Yang KH, Jeong TC, Delany B, Kaminski NE. 2-Acetylaminofluorene inhibits the activation of immune responses by blocking cell cycle progression at G1 phase. Archives of Toxicology. 69: 350-6. PMID 7654142 DOI: 10.1007/s002040050183 |
0.324 |
|
| 1995 |
Lee M, Kyu Hwan Yang, Kaminski NE. Effects of putative cannabinoid receptor ligands, anandamide and 2- arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes Journal of Pharmacology and Experimental Therapeutics. 275: 529-536. PMID 7473135 |
0.403 |
|
| 1994 |
Delaney B, Strom SC, Collins S, Kaminski NE. Carbon Tetrachloride Suppresses T-Cell-Dependent Immune Responses by Induction of Transforming Growth Factor-1 Toxicology and Applied Pharmacology. 126: 98-107. PMID 8184439 DOI: 10.1006/taap.1994.1095 |
0.437 |
|
| 1994 |
Delaney B, Kaminski NE. Induction of serum borne immunomodulatory factors in B6C3F1 mice by carbon tetrachloride. Exposure to carbon tetrachloride produces an increase in B-cell number and function Toxicology. 88: 201-212. PMID 8160201 DOI: 10.1016/0300-483X(94)90121-X |
0.327 |
|
| 1994 |
Kaminski NE, Koh WS, Yang KH, Lee M, Kessler FK. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochemical Pharmacology. 48: 1899-908. PMID 7986201 DOI: 10.1016/0006-2952(94)90588-6 |
0.331 |
|
| 1993 |
Delaney B, Koh WS, Yang KH, Strom SC, Kaminski NF. Hepatocyte growth factor enhances B-cell activity Life Sciences. 53. PMID 8336516 DOI: 10.1016/0024-3205(93)90654-L |
0.306 |
|
| 1993 |
Schatz AR, Koh WS, Kaminski NE. Δ9-tetrahydrocannabinol selectivity inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function Immunopharmacology. 26: 129-137. PMID 8282537 DOI: 10.1016/0162-3109(93)90005-B |
0.397 |
|
| 1993 |
Delaney B, Kaminski NE. High concentrations of interleukin-2 selectively suppress T-cell dependent humoral immune responses Immunopharmacology. 26: 119-127. PMID 8282536 DOI: 10.1016/0162-3109(93)90004-A |
0.365 |
|
| 1992 |
Kaminski NE, Holsapple MP. A functional characterization of macrophage alterations in casein-treated B6C3F1 mice Immunopharmacology. 24: 229-240. PMID 1478855 DOI: 10.1016/0162-3109(92)90078-Q |
0.414 |
|
| 1992 |
Kaminski NE, Stevens WD. The role of metabolism in carbon tetrachloride-mediated immunosuppression. In vitro studies. Toxicology. 75: 175-88. PMID 1462354 DOI: 10.1016/0300-483X(92)90156-9 |
0.34 |
|
| 1992 |
Schatz AR, Kessler FK, Kaminski NE. Inhibition of adenylate cyclase by Δ9-Tetrahydrocannabinol in mouse spleen cells: A potential mechanism for cannabinoid- mediated immunosuppression Life Sciences. 51. PMID 1321935 DOI: 10.1016/0024-3205(92)90414-K |
0.324 |
|
| 1989 |
Kaminski NE, Jordan SD, Holsapple MP. Suppression of humoral and cell-mediated immune responses by carbon tetrachloride Fundamental and Applied Toxicology. 12: 117-128. PMID 2925010 DOI: 10.1016/0272-0590(89)90067-5 |
0.305 |
|
| 1987 |
Johnson KW, Kaminski NE, Munson AE. Direct suppression of cultured spleen cell responses by chlordane and the basis for differential effects on in vivo and in vitro immunocompetence Journal of Toxicology and Environmental Health. 22: 497-515. PMID 3694709 DOI: 10.1080/15287398709531089 |
0.315 |
|
| 1987 |
Kaminski NE, Holsapple MP. Inhibition of macrophage accessory cell function in casein-treated B6C3F1 mice Journal of Immunology. 139: 1804-1810. PMID 3624870 |
0.384 |
|
| Show low-probability matches. |